Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Chemotherapy Clinical Trials

A listing of Chemotherapy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1317) clinical trials

The purpose of this study is to examine whether removing some of the lymph nodes from the arm pit, but not removing them all, followed with radiation therapy will be as good as having the majority of the lymph nodes from the arm pit removed during breast surgery followed with ...

Phase N/A

Researchers at the University of Kentucky are seeking candidates to participate in a study for possibvle new cancer treatment. Exatherm Total Body Hyperthermia System (Exatherm-TBH) is an investigational medical device treatment that will be performed in an inpatient setting and lasts approximately four hours.

Phase N/A

The primary efficacy objective of the study is to evaluate the efficacy of 16 cycles of Atezolizumab (MPDL3280A) treatment compared with best supportive care as measured by disease-free survival (DFS) as assessed by the investigator.

Phase

This randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel with or without bevacizumab compared with treatment with carboplatin plus (+) paclitaxel and bevacizumab in chemotherapy-naïve patients with Stage IV non-squamous non-small cell lung cancer (NSCLC).

Phase

This study is being done to see how safe an investigational drug is and how well it will work to help people with advanced lung cancer in patients who have a specific type of lung cancer with a KRAS mutation that has already been treated with prior therapies. The test ...

Phase

Approximately 145 patients will be randomised using an Interactive Voice Response System /Interactive Web Response System (IVR/IWR system) in a 3:2 ratio (Olaparib:placebo) to the treatments as specified below: Olaparib tablets p.o. 300 mg twice daily Matching placebo tablets p.o. twice daily Eligible patients will be those patients with pancreas ...

Phase

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00626990?term=RTOG-0834&rank=1

Phase